The companies will begin discussions with the US Food and Drug Administration (FDA) to prepare for regulatory submission.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.